查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571655

眼科黏性手術器械市場規模、佔有率和趨勢分析報告：按類型、來源、應用、地區、細分市場預測，2024-2030年

Ophthalmic Viscosurgical Devices Market Size, Share & Trends Analysis Report By Type (Dispersive, Cohesive Viscoadaptive), By Source (Animal, Biological & Semi-synthetic), By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

眼科黏性手術器械市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，到2030年，全球眼科黏稠手術器械市場規模將達到6.395億美元，2024年至2030年的複合年成長率預計將達到6.3%。

老年人口的穩定成長和眼科疾病的高盛行率預計將推動成長。眼科醫療設施的不斷發展預計將在不久的將來增加對眼科黏性手術設備（OVD）的需求。

糖尿病盛行率的增加預計將成為推動市場成長的主要因素。 1 型和第 2 型糖尿病患者在某些時候更有可能患有白內障。目前，白內障的唯一治療方法是手術，因此對白內障手術必需的眼科黏彈劑的需求正在增加。此外，印度、日本、美國和西歐國家等國家的白內障手術率（CSR）也不斷增加，導致全球白內障負擔增加。

積極的政府和非政府舉措，如眼科檢查計劃、州和國家眼保健系統、眼科培訓和教育計劃，預計將在眼科黏性手術設備市場的成長中發揮重要作用。例如，世界糖尿病基金會為低度開發經濟體的初級保健眼科 HCP 開展培訓和發展計劃，以提高白內障治療方法的傳播和認知。

適用於常規和複雜眼科手術各個階段的超黏性和黏性OVD等先進黏彈性材料新興市場的開拓是一種新興趨勢。例如，黏性 OVD 將黏性 OVD 和分散 OVD 結合在一個注射器中，使其適用於複雜的白內障手術和眼外傷病例。

眼科黏性手術器械市場報告亮點：

  • 按類型分類，內聚式 OVD 和分散式 OVD 共同佔據了很大的市場佔有率，因為它們同時用於眼科手術。由於複雜眼科手術的增加，使用黏性 OVD 改善了手術結果等因素，黏性 OVD 預計在預測期內也將實現健康的複合年成長率。
  • 從應用來看，白內障手術領域在 2023 年佔據最大的市場佔有率，預計在預測期內將顯著成長。糖尿病盛行率上升、老年人口增加以及有利的眼保健政策是預計推動成長的一些因素。 OVD 在青光眼和玻璃體切除手術等眼科手術中的廣泛應用預計將出現成長並推動市場成長。
  • 2023年，北美佔據眼科黏稠手術器械市場的最大佔有率。由於眼保健設施的改善和大量患者群的存在，預計亞太地區在預測期內將以最快的複合年成長率成長。
  • 預計來自合成原料的黏彈性體在預測期內將呈現良好的成長率。這是由於與動物黏彈性材料相比，精製成本更低、產量更高且萃取過程更容易。一個新的趨勢是透過基因工程宿主細菌來生產含有低水平內毒素的黏彈劑來提高純度。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章眼科黏性手術器械市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 眼科 Visco 手術器械市場分析工具
    • 波特的分析
    • PESTEL分析

第4章眼科黏性手術器械市場：類型估計與趨勢分析

  • 細分儀表板
  • 眼科 Visco 手術器械市場：2023 年和 2030 年類型變化分析
  • 去中心化
  • 凝聚力
  • 黏度自適應型

第5章眼科黏性手術器械市場：來源估計與趨勢分析

  • 細分儀表板
  • 眼科黏性手術器械市場：來源變化分析，2023-2030
  • 動物
  • 生物
  • 半合成

第6章眼科黏性手術器械市場：應用估算與趨勢分析

  • 細分儀表板
  • 眼科黏性手術器械市場：2023 年和 2030 年應用變化分析
  • 白內障手術
  • 青光眼手術
  • 角膜移植
  • 玻璃體視網膜移植

第7章眼科黏性手術器械市場：區域估計與趨勢分析

  • 2023 年和 2030 年眼科 Visco 手術器械按地區市場佔有率（百萬美元）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Bausch + Lomb
    • Carl Zeiss Meditec AG
    • Johnson & Johnson Services, Inc.
    • Alcon
    • Rayner Group
    • Bohus BioTech AB
    • BVI
    • Nordic Pharma, Inc.
    • Truviz Ophthalmic
簡介目錄
Product Code: GVR-3-68038-887-9

Ophthalmic Viscosurgical Devices Market Growth & Trends:

The global ophthalmic viscosurgical devices market size is anticipated to reach USD 639.5 million by 2030, registering a CAGR of 6.3% from 2024 to 2030, according to a new report published by Grand View Research, Inc. Steady rise in geriatric population coupled with high prevalence of ocular disorders is expected to drive the growth. Constantly developing ophthalmic care facilities are expected to contribute to the demand for Ophthalmic Viscosurgical Devices (OVDs) in near future.

Increasing prevalence of diabetes is expected to be a major factor boosting the market growth. Patients with both type 1 and type 2 diabetes are prone to develop cataract at some point in time. Currently, the surgical procedure is the only treatment option for cataract, thereby driving the demand for ophthalmic viscosurgical devices-an integral part of the cataract surgery. Furthermore, the global burden of cataract can be subjected to the increasing Cataract Surgical Rate (CSR) in countries, such as India, Japan, U.S., and several Western European countries.

Favorable government and non-government initiatives, such as ophthalmic screening programs, state and national eye care schemes, ophthalmic training, and education programs are expected to play a significant role in the ophthalmic viscosurgical devices market growth. For instance, the World Diabetes Foundation conducts training and development programs for ophthalmic HCP at primary care in regions of underdeveloped economies, improving the reach and awareness of cataract treatment procedures.

Developing advanced viscoelastics such as super-cohesive and viscoadpative OVD suitable for each stages of routine and complex ocular surgery is an emerging trend in the market. For instance, the viscoadpative OVDs have the combined benefit of cohesive and dispersive OVDs contained in a single syringe suitable for complex cataract surgery and ocular trauma cases.

Ophthalmic Viscosurgical Devices Market Report Highlights:

  • Based on the type, as cohesive and dispersive OVDs are used concomitantly in ocular surgical procedures they together held significant share in the market. In addition, the viscoadaptive OVDs segment is expected to register a healthy CAGR over the forecast period, attributed to factors such as improved surgical outcomes on usage of viscoadpative OVD coupled with increasing number of complex ocular procedures.
  • Based on application, the cataract surgery segment held the largest market share in 2023 and is expected to grow at a significant rate over the forecast period. Rising prevalence of diabetes, expanding geriatric population, favorable eye care policies are some of the factors expected to fuel the growth. Expanding OVDs application into ocular surgeries such as glaucoma and vitrectomy surgery are expected to witness growth, driving the market growth.
  • North America held the largest ophthalmic viscosurgical devices market share in 2023. Asia pacific is expected to expand at a speediest CAGR over the forecast period due to the improving access to ophthalmic care facilities and presence of large patient pool.
  • Viscoelastics derived from synthetic sources is expected to grow at a lucrative rate over the forecast period. This can be attributed to its low purification cost, high percentage of yield and easy extraction process compared to viscoelastic from animal source. The emerging trend is genetically engineering host bacteria to produce viscoelastic with low level of endotoxins thereby enhanced purity.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Ophthalmic Viscosurgical Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Ophthalmic Viscosurgical Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Ophthalmic Viscosurgical Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Ophthalmic Viscosurgical Devices Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Dispersive
    • 4.3.1. Dispersive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cohesive
    • 4.4.1. Cohesive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Viscoadaptive
    • 4.5.1. Viscoadaptive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Viscosurgical Devices Market: Source Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Ophthalmic Viscosurgical Devices Market: Source Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Animal
    • 5.3.1. Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Biological
    • 5.4.1. Biological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Semi-synthetic
    • 5.5.1. Semi-synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Viscosurgical Devices Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Ophthalmic Viscosurgical Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Cataract Surgery
    • 6.3.1. Cataract Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Glaucoma Surgery
    • 6.4.1. Glaucoma Surgery Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Corneal Grafting
    • 6.5.1. Corneal Grafting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Vitreoretinal Grafting
    • 6.6.1. Vitreoretinal Grafting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Viscosurgical Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Ophthalmic Viscosurgical Devices Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Bausch + Lomb
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Carl Zeiss Meditec AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Johnson & Johnson Services, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Alcon
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Rayner Group
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bohus BioTech AB
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. BVI
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Nordic Pharma, Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Truviz Ophthalmic
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives